Form 8-K - Current report:
SEC Accession No. 0001558370-22-009711
Filing Date
2022-06-03
Accepted
2022-06-03 16:00:14
Documents
12
Period of Report
2022-05-31
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20220531x8k.htm   iXBRL 8-K 38766
  Complete submission text file 0001558370-22-009711.txt   156493

Data Files

Seq Description Document Type Size
2 EX-101.SCH glyc-20220531.xsd EX-101.SCH 3395
3 EX-101.LAB glyc-20220531_lab.xml EX-101.LAB 15365
4 EX-101.PRE glyc-20220531_pre.xml EX-101.PRE 10384
6 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20220531x8k_htm.xml XML 4658
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 22994206
SIC: 2834 Pharmaceutical Preparations